Published in J Neurosci Res on June 15, 2005
Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imaging (2008) 2.41
Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci (2007) 1.73
Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation. J Neurosci (2009) 1.39
Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma. Invest Ophthalmol Vis Sci (2011) 1.35
Gene expression and phenotypic characterization of mouse heart after chronic constant or intermittent hypoxia. Physiol Genomics (2005) 1.18
Glial connexins and gap junctions in CNS inflammation and disease. J Neurochem (2008) 1.17
The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system. J Neuroimmune Pharmacol (2012) 1.13
Similar transcriptomic alterations in Cx43 knockdown and knockout astrocytes. Cell Commun Adhes (2008) 1.07
The TLR3 ligand polyI: C downregulates connexin 43 expression and function in astrocytes by a mechanism involving the NF-kappaB and PI3 kinase pathways. Glia (2006) 1.01
Integrated transcriptomic response to cardiac chronic hypoxia: translation regulators and response to stress in cell survival. Funct Integr Genomics (2008) 0.96
Organizational principles of the connexin-related brain transcriptome. J Membr Biol (2007) 0.94
Intracellular polyamines enhance astrocytic coupling. Neuroreport (2012) 0.93
Modulation of astrocyte P2Y1 receptors by the carboxyl terminal domain of the gap junction protein Cx43. Glia (2008) 0.93
Gap junctions and hemichannels composed of connexins: potential therapeutic targets for neurodegenerative diseases. Front Cell Neurosci (2014) 0.91
Astrocyte regulation of CNS inflammation and remyelination. Brain Sci (2013) 0.90
Post-translational modifications in the rat lumbar spinal cord in experimental autoimmune encephalomyelitis. J Proteome Res (2007) 0.90
New advances on glial activation in health and disease. World J Virol (2015) 0.87
A stochastic two-dimensional model of intercellular Ca2+ wave spread in glia. Biophys J (2005) 0.86
Lipopolysaccharide induces degradation of connexin43 in rat astrocytes via the ubiquitin-proteasome proteolytic pathway. PLoS One (2013) 0.85
Connexin Type and Fluorescent Protein Fusion Tag Determine Structural Stability of Gap Junction Plaques. J Biol Chem (2015) 0.84
Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis optica. PLoS One (2013) 0.82
Influence of drugs on gap junctions in glioma cell lines and primary astrocytes in vitro. Front Physiol (2014) 0.80
Gene expression in the spinal cord in female lewis rats with experimental autoimmune encephalomyelitis induced with myelin basic protein. PLoS One (2012) 0.79
Alteration of transcriptomic networks in adoptive-transfer experimental autoimmune encephalomyelitis. Front Integr Neurosci (2007) 0.78
Fluoxetin upregulates connexin 43 expression in astrocyte. Basic Clin Neurosci (2014) 0.77
Hippocampus-based contextual memory alters the morphological characteristics of astrocytes in the dentate gyrus. Mol Brain (2016) 0.76
Mouse Hepatitis Virus Infection Remodels Connexin43-Mediated Gap Junction Intercellular Communication In Vitro and In Vivo. J Virol (2015) 0.75
Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease. Acta Neuropathol Commun (2016) 0.75
Gap junctions and hemichannels: communicating cell death in neurodevelopment and disease. BMC Cell Biol (2017) 0.75
Th1 cells downregulate connexin 43 gap junctions in astrocytes via microglial activation. Sci Rep (2016) 0.75
Gastric electrical stimulation improves enteric neuronal survival. Int J Mol Med (2017) 0.75
Connexin 43-Mediated Astroglial Metabolic Networks Contribute to the Regulation of the Sleep-Wake Cycle. Neuron (2017) 0.75
Axonal transection in the lesions of multiple sclerosis. N Engl J Med (1998) 12.21
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med (2002) 8.33
Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci (2004) 5.70
Axonal damage in acute multiple sclerosis lesions. Brain (1997) 3.88
Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med (2000) 3.20
The morbid anatomy of the demyelinative disease. Am J Med (1952) 3.17
Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol (2000) 2.99
Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain (2000) 2.90
Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci (1999) 2.43
Cell-specific expression of connexins and evidence of restricted gap junctional coupling between glial cells and between neurons. J Neurosci (2001) 2.28
Connexins and gap junctions of astrocytes and oligodendrocytes in the CNS. Brain Res Brain Res Rev (2000) 1.99
Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain (2001) 1.91
Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab Invest (1981) 1.84
Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol (2001) 1.78
Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines. Mol Vis (2003) 1.77
Gap junctions and connexin expression in the normal and pathological central nervous system. Biol Cell (2002) 1.77
The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol Today (1994) 1.73
Connexin30 in rodent, cat and human brain: selective expression in gray matter astrocytes, co-localization with connexin43 at gap junctions and late developmental appearance. Neuroscience (1999) 1.66
Experimental allergic encephalomyelitis: role of fibrin deposition in immunopathogenesis of inflammation in rats. Fed Proc (1976) 1.62
Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. J Neurosci (2002) 1.62
Connexin43 null mice reveal that astrocytes express multiple connexins. Brain Res Brain Res Rev (2000) 1.61
The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis. Glia (1995) 1.55
Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology (2001) 1.53
Behavioral and histological outcomes following graded spinal cord contusion injury in the C57Bl/6 mouse. Exp Neurol (2001) 1.51
Specific gap junctions enhance the neuronal vulnerability to brain traumatic injury. J Neurosci (2002) 1.43
Transfer of biologically important molecules between cells through gap junction channels. Curr Med Chem (2003) 1.32
Identification of cells expressing Cx43, Cx30, Cx26, Cx32 and Cx36 in gap junctions of rat brain and spinal cord. Cell Commun Adhes (2001) 1.31
Immunological update on multiple sclerosis. Curr Opin Neurol (2001) 1.28
Ischemia-induced brain damage depends on specific gap-junctional coupling. J Cereb Blood Flow Metab (2002) 1.24
Array analysis of gene expression in connexin-43 null astrocytes. Physiol Genomics (2003) 1.24
IL-1beta differentially regulates calcium wave propagation between primary human fetal astrocytes via pathways involving P2 receptors and gap junction channels. Proc Natl Acad Sci U S A (1999) 1.23
Acute downregulation of Cx43 alters P2Y receptor expression levels in mouse spinal cord astrocytes. Glia (2003) 1.21
Genes controlling multiple functional pathways are transcriptionally regulated in connexin43 null mouse heart. Physiol Genomics (2004) 1.20
Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke. J Neurosurg (1997) 1.18
Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis. Lab Invest (1984) 1.17
Sensitivity of the brain transcriptome to connexin ablation. Biochim Biophys Acta (2004) 1.14
Immunocytochemical staining for glial fibrillary acidic protein and the metabolism of cytoskeletal proteins in experimental allergic encephalomyelitis. Brain Res (1983) 1.11
Elevated connexin43 immunoreactivity at sites of amyloid plaques in Alzheimer's disease. Brain Res (1996) 1.09
Genetic influences on secondary degeneration and wound healing following spinal cord injury in various strains of mice. J Comp Neurol (2002) 1.08
Astrocytic response to injury. Prog Brain Res (1992) 1.08
Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J Neuroimmunol (2001) 1.04
Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumour necrosis factor. Cytokine (1999) 1.01
The effect of gammadelta T cell depletion on cytokine gene expression in experimental allergic encephalomyelitis. J Immunol (1998) 1.01
Insights into the aetiology and pathogenesis of multiple sclerosis. Immunol Cell Biol (1998) 0.99
Demonstration of interleukin-1 beta in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level. J Neuroimmunol (1993) 0.98
Murine experimental autoimmune encephalomyelitis: a model of immune-mediated inflammation and multiple sclerosis. Methods Enzymol (1997) 0.98
Connexin43 null mutation increases infarct size after stroke. J Comp Neurol (2001) 0.97
Astrocyte and oligodendrocyte connexins of the glial syncytium in relation to astrocyte anatomical domains and spatial buffering. Cell Commun Adhes (2003) 0.95
Connexin43 and astrocytic gap junctions in the rat spinal cord after acute compression injury. J Comp Neurol (1997) 0.95
Neuroprotective role of astrocytic gap junctions in ischemic stroke. Cell Commun Adhes (2003) 0.95
Mechanisms of edema formation in experimental autoimmune encephalomyelitis. The contribution of inflammatory cells. Am J Pathol (1990) 0.92
Brain macrophages inhibit gap junctional communication and downregulate connexin 43 expression in cultured astrocytes. Eur J Neurosci (2002) 0.92
Molecular physiology of gap junction channels. Clin Exp Pharmacol Physiol (1996) 0.90
Expression of the connexin 43 gene is increased in the kidneys and the lungs of rats injected with bacterial lipopolysaccharide. Shock (1998) 0.90
Effective reduction of neuronal death by inhibiting gap junctional intercellular communication in a rodent model of global transient cerebral ischemia. Exp Neurol (2001) 0.89
Immune cell entry to the CNS--a focus for immunoregulation of EAE. Res Immunol (1999) 0.89
Experimental autoimmune encephalomyelitis. An anatomically-based explanation of clinical progression in rodents. J Neuroimmunol (1982) 0.89
Glial cells as targets for cytotoxic immune mediators. Glia (2001) 0.88
AMPA/kainate receptors in mouse spinal cord cell-specific display of receptor subunits by oligodendrocytes and astrocytes and at the nodes of Ranvier. Glia (2003) 0.87
MK-801 limits neurovascular dysfunction during experimental allergic encephalomyelitis. J Pharmacol Exp Ther (1997) 0.86
Gene-expression profiling of experimental autoimmune encephalomyelitis. Neurochem Res (2002) 0.86
A brain slice model for in vitro analyses of astrocytic gap junction and connexin43 regulation: actions of ischemia, glutamate and elevated potassium. Eur J Neurosci (2000) 0.85
Dissociation of GFAP intermediate filaments in EAE: observations in the lumbar spinal cord. Glia (1989) 0.84
Astrocytic gap junction removal, connexin43 redistribution, and epitope masking at excitatory amino acid lesion sites in rat brain. Glia (1995) 0.84
Edema of the spinal cord in experimental allergic encephalomyelitis. Proc Soc Exp Biol Med (1966) 0.83
CNS gene expression pattern associated with spontaneous experimental autoimmune encephalomyelitis. J Neurosci Res (2003) 0.82
The role of cytokines in experimental autoimmune encephalomyelitis. Arch Immunol Ther Exp (Warsz) (2000) 0.81
On the role of peripheral macrophages during active experimental allergic encephalomyelitis (EAE). J Neural Transm (Vienna) (2001) 0.80
The enhancement of glucose uptake caused by the collapse of gap junction communication is due to an increase in astrocyte proliferation. J Neurochem (2001) 0.79
Pathophysiological aspects of acute experimental allergic encephalomyelitis. Acta Neurol Scand Suppl (1988) 0.78
N-methyl-D-aspartate receptor-mediated events contribute to neurovascular breakdown during experimental allergic encephalomyelitis. Biochem Soc Trans (1997) 0.78
Gap junctions in health and disease. Virchows Arch (1998) 0.77
Some pathophysiological aspects of experimental autoimmune encephalomyelitis. Schweiz Rundsch Med Prax (1989) 0.77
Glial fibrillary acidic protein in acute and chronic relapsing experimental allergic encephalomyelitis (EAE). Prog Clin Biol Res (1984) 0.77
Does damage of perivascular astrocytes in multiple sclerosis plaques participate in blood-brain barrier permeability? Neuropatol Pol (1992) 0.77
Gene microarrays and experimental demyelinating disease: a tool to enhance serendipity. Brain (2001) 0.76
Metal-assisted chemical etching of silicon: a review. Adv Mater (2011) 4.44
Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cells. Cell Cycle (2011) 3.49
Pannexin1 is part of the pore forming unit of the P2X(7) receptor death complex. FEBS Lett (2007) 3.19
P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling. J Neurosci (2006) 3.14
The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J Biol Chem (2009) 2.90
Spatial and temporal control of cofilin activity is required for directional sensing during chemotaxis. Curr Biol (2006) 2.86
Potent block of Cx36 and Cx50 gap junction channels by mefloquine. Proc Natl Acad Sci U S A (2004) 2.61
Pannexin 1: the molecular substrate of astrocyte "hemichannels". J Neurosci (2009) 2.48
The role of the glycocalyx in reorganization of the actin cytoskeleton under fluid shear stress: a "bumper-car" model. Proc Natl Acad Sci U S A (2004) 2.05
Structural changes in the carboxyl terminus of the gap junction protein connexin43 indicates signaling between binding domains for c-Src and zonula occludens-1. J Biol Chem (2004) 2.03
Associative transcriptomics of traits in the polyploid crop species Brassica napus. Nat Biotechnol (2012) 1.96
Genome-wide association mapping to candidate polymorphism resolution in the unsequenced barley genome. Proc Natl Acad Sci U S A (2010) 1.96
Imaging the endothelial glycocalyx in vitro by rapid freezing/freeze substitution transmission electron microscopy. Arterioscler Thromb Vasc Biol (2011) 1.89
Glial cells in (patho)physiology. J Neurochem (2012) 1.89
Connexin and pannexin mediated cell-cell communication. Neuron Glia Biol (2007) 1.86
Pannexin channels are not gap junction hemichannels. Channels (Austin) (2011) 1.84
A global analysis of the impacts of urbanization on bird and plant diversity reveals key anthropogenic drivers. Proc Biol Sci (2014) 1.78
Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry (2002) 1.66
Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis (2009) 1.60
pH-dependent intramolecular binding and structure involving Cx43 cytoplasmic domains. J Biol Chem (2002) 1.59
Mechanisms of glutamate release from astrocytes: gap junction "hemichannels", purinergic receptors and exocytotic release. Neurochem Int (2004) 1.53
The role of connexins in controlling cell growth and gene expression. Prog Biophys Mol Biol (2007) 1.48
Connexins, pannexins, innexins: novel roles of "hemi-channels". Pflugers Arch (2008) 1.45
Gap junctions mediate bystander cell death in developing retina. J Neurosci (2003) 1.43
Targeting pannexin1 improves seizure outcome. PLoS One (2011) 1.43
Regulation of connexin43 protein complexes by intracellular acidification. Circ Res (2003) 1.43
The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes. Glia (2005) 1.42
Ordered arrays of silicon nanowires produced by nanosphere lithography and molecular beam epitaxy. Nano Lett (2005) 1.38
Semiconductor nanowires: from self-organization to patterned growth. Small (2006) 1.36
Blockade of gap junctions in vivo provides neuroprotection after perinatal global ischemia. Stroke (2005) 1.36
Gap junction remodeling and cardiac arrhythmogenesis in a murine model of oculodentodigital dysplasia. Proc Natl Acad Sci U S A (2007) 1.33
The neuronal connexin36 interacts with and is phosphorylated by CaMKII in a way similar to CaMKII interaction with glutamate receptors. Proc Natl Acad Sci U S A (2008) 1.28
New possible roles for aquaporin-4 in astrocytes: cell cytoskeleton and functional relationship with connexin43. FASEB J (2005) 1.28
pH-dependent dimerization of the carboxyl terminal domain of Cx43. Biophys J (2004) 1.26
Array analysis of gene expression in connexin-43 null astrocytes. Physiol Genomics (2003) 1.24
ATP signaling is deficient in cultured Pannexin1-null mouse astrocytes. Glia (2012) 1.22
Closure of gap junction channels by arylaminobenzoates. Mol Pharmacol (2003) 1.21
Acute downregulation of Cx43 alters P2Y receptor expression levels in mouse spinal cord astrocytes. Glia (2003) 1.21
Genes controlling multiple functional pathways are transcriptionally regulated in connexin43 null mouse heart. Physiol Genomics (2004) 1.20
Block of specific gap junction channel subtypes by 2-aminoethoxydiphenyl borate (2-APB). J Pharmacol Exp Ther (2006) 1.20
Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol Res (2003) 1.19
Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging. J Nanobiotechnology (2011) 1.19
Gene expression and phenotypic characterization of mouse heart after chronic constant or intermittent hypoxia. Physiol Genomics (2005) 1.18
Fluid shear stress remodels expression and function of junctional proteins in cultured bone cells. Am J Physiol Cell Physiol (2002) 1.18
Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA. J Infect Dis (2008) 1.16
Exocytosis of ATP from astrocyte progenitors modulates spontaneous Ca2+ oscillations and cell migration. Glia (2007) 1.16
Stimulus-induced and state-dependent sustained gamma activity is tightly coupled to the hemodynamic response in humans. J Neurosci (2009) 1.16
Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model. J Infect Dis (2008) 1.16
Autophagy modulates dynamics of connexins at the plasma membrane in a ubiquitin-dependent manner. Mol Biol Cell (2012) 1.15
Sensitivity of the brain transcriptome to connexin ablation. Biochim Biophys Acta (2004) 1.14
Mefloquine blockade of Pannexin1 currents: resolution of a conflict. Cell Commun Adhes (2009) 1.12
Gene expression alterations in connexin null mice extend beyond the gap junction. Neurochem Int (2004) 1.12
Modifications in the biophysical properties of connexin43 channels by a peptide of the cytoplasmic loop region. Circ Res (2004) 1.11
Flow cytometry analysis of gap junction-mediated cell-cell communication: advantages and pitfalls. Cytometry A (2006) 1.10
Acquired infection with Toxoplasma gondii in adult mice results in sensorimotor deficits but normal cognitive behavior despite widespread brain pathology. Microbes Infect (2010) 1.09
A comparative antibody analysis of pannexin1 expression in four rat brain regions reveals varying subcellular localizations. Front Pharmacol (2013) 1.09
Cardiac connexins: genes to nexus. Adv Cardiol (2006) 1.08
Formation of the gap junction nexus: binding partners for connexins. J Physiol Paris (2002) 1.08
Similar transcriptomic alterations in Cx43 knockdown and knockout astrocytes. Cell Commun Adhes (2008) 1.07
Automated cell-based assay for screening of aquaporin inhibitors. Anal Chem (2009) 1.06
PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity. J Neurosci Res (2007) 1.06
Discovery and development of exome-based, co-dominant single nucleotide polymorphism markers in hexaploid wheat (Triticum aestivum L.). Plant Biotechnol J (2012) 1.05
Sequence-specific resonance assignment of the carboxyl terminal domain of Connexin43. J Biomol NMR (2002) 1.04
Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy. J Infect Dis (2010) 1.04
Transfection of mammalian cells with connexins and measurement of voltage sensitivity of their gap junctions. Nat Protoc (2006) 1.04
Ag-assisted CBE growth of ordered InSb nanowire arrays. Nanotechnology (2010) 1.03
Regulation of connexin43-protein binding in astrocytes in response to chemical ischemia/hypoxia. J Biol Chem (2004) 1.02
Chagas heart disease: report on recent developments. Cardiol Rev (2012) 1.02
Bidirectional calcium signaling between satellite glial cells and neurons in cultured mouse trigeminal ganglia. Neuron Glia Biol (2009) 1.01
The TLR3 ligand polyI: C downregulates connexin 43 expression and function in astrocytes by a mechanism involving the NF-kappaB and PI3 kinase pathways. Glia (2006) 1.01
Stage-specific global alterations in the transcriptomes of Lyme disease spirochetes during tick feeding and following mammalian host adaptation. Mol Microbiol (2014) 1.00
Microarray technology in the investigation of diseases of myocardium with special reference to infection. Front Biosci (2006) 1.00
Two non-vesicular ATP release pathways in the mouse erythrocyte membrane. FEBS Lett (2011) 1.00
Persistent cognitive and motor deficits after successful antimalarial treatment in murine cerebral malaria. Microbes Infect (2010) 1.00
Vertical III-V nanowire device integration on Si(100). Nano Lett (2014) 0.99
PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol (2013) 0.99
Transcriptomic changes in developing kidney exposed to chronic hypoxia. Biochem Biophys Res Commun (2006) 0.98
Characterization of hTERT-immortalized osteoblast cell lines generated from wild-type and connexin43-null mouse calvaria. Am J Physiol Cell Physiol (2010) 0.98
Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis. Exp Neurol (2004) 0.98
Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model. Sci Rep (2013) 0.98